Skip to main content
Triangle logo TriangleGet started

Keto Diet (NCT05708352)

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment: a one-minute explainerNCT057083521 min

Keto Diet trial for Glioblastoma Multiforme (NCT05708352). This is a short film with English narration. The transcript is on this page, and the written brief is separate.

What the film says

Read the transcript

This trial is for adults diagnosed with glioblastoma within two months who have not started chemotherapy or radiation. Patients need a performance score of at least seventy and English or Spanish literacy.

The idea: an eighteen-week ketogenic diet increases fat relative to protein and carbohydrate intake. Patients are randomized to this diet or standard dietary guidance, with dietitian support. Everyone receives standard cancer treatment. Ketone and glucose measurements track adherence; researchers test whether survival differs between groups.

This phase 2 study plans 170 patients. Jethro Hu leads at Cedars-Sinai; four US sites recruit.

Public record; not medical advice.

Read the full brief →

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.